Aktuell 2024/04/23 BGG aus China eröffnet Hauptsitz in Basel BGG richtet in Basel einen neuen globalen Hauptsitz ein und will von dort aus in Europa und den USA expandieren. Das Pekinger Unternehmen ist ein...
News 2024/04/23 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
Success stories 2024/05/02 BeiGene promuove l’accesso globale ai trattamenti antitumorali: ecco come Dalla sede europea di Basilea, in Svizzera, BeiGene collabora strategicamente con stakeholder in tutto il mondo per far progredire la ricerc...
News 2024/03/26 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 2023/11/03 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 2023/10/18 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 2023/08/03 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Aktuell 2023/08/03 Worg erhält Finanzierung von 130 Millionen Franken Das biopharmazeutische chinesische Unternehmen Worg Pharma mit Europasitz in der Basel Area hat in einer Finanzierungsrunde der Serie C umgerechn...
Spotlight 2023/06/15 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Aktuell 2020/09/01 Polyphor schliesst exklusiven Lizenzvertrag für China Die in der Basel Area ansässige Firma Polyphor hat mit Fosun Pharma eine Vereinbarung getroffen. Die chinesische Fosun Pharma wird Polyphors Wirk...
News 2020/09/01 Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead clinical dev...
Actualités 2022/10/26 Le fabricant chinois de vaccins CanSino Biologics s’installe à Genève pour lancer son vaccin Covid inhalé Ce premier vaccin Covid inhalé a été approuvé par les autorités chinoises il y a un mois. Cette technologie a également le potentiel de protéger ...
News 2022/11/23 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
Noticias 2018/01/30 La empresa china de nutrición Biostime elige a Ginebra para su expansión internacional El Biostime Institute for Nutrition and Care (BINC) es la primera plataforma de investigación del grupo fuera de China.
News 2023/05/26 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Actualités 2021/09/13 Incyte inaugure sa nouvelle usine de production à Yverdon Après avoir installé en 2020 son siège européen à Morges, le groupe biopharmaceutique américain Incyte renforce sa présence dans le canton de Vau...
News 2022/10/26 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...